Lupin acquires Southern Cross Pharma in Australia

Lupin acquires Southern Cross Pharma in Australia

by admin- Friday, July 30th, 2021 05:32:37 PM

Lupin has entered right into a definitive settlement under which Lupin will accumulate a hundred% of the shares of Southern Cross Pharma Pty Ltd (SCP).

Incorporated in Melbourne, Australia, SCP is engaged in growing, registering, and dispensing regularly occurring merchandise. As a part of the transaction, Generic Health will advantage access to over 60 registered merchandise having sales of over AUD 30 Mn (approximately USD 22 Mn). This will extensively growth Lupin’s price proposition and market proportion within the Australian market.

News Updates